Syndax Pharmaceuticals Inc Quarterly Unrecognized Tax Benefits in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Syndax Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2013 to Q4 2023.
  • Syndax Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $143K, unchanged year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $143K $0 0% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $143K -$20K -12.3% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $163K $0 0% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $163K $0 0% Dec 31, 2020 10-K 2024-02-27
Q4 2019 $163K $0 0% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $163K $0 0% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $163K -$78K -32.4% Dec 31, 2017 10-K 2021-03-12
Q4 2016 $241K $0 0% Dec 31, 2016 10-K 2020-03-05
Q4 2015 $241K $0 0% Dec 31, 2015 10-K 2019-03-07
Q4 2014 $241K -$439K -64.6% Dec 31, 2014 10-K 2018-03-08
Q4 2013 $680K Dec 31, 2013 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.